Selective Vascular Endothelial Growth Factor Receptor Inhibitors Provide Limited Benefits for Metastatic Colorectal Cancer: A Meta-Analysis - Fan, Qin; Lv, Wenhao; Xu, Yuexin; Dong, Yuan; Xiang, Zhiqiang; Wang, Junjie (Current pharmaceutical design, 2020)
Keywords: Antibodies, Monoclonal - therapeutic use; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab - therapeutic use; Cetuximab - therapeutic use; Colorectal Neoplasms - drug therapy; Fluorouracil; Humans; Receptors, Vascular Endothelial Growth Factor - therapeutic use; Treatment Outcome; meta-analysis; VEGFR inhibitor; randomized controlled trials; chemotherapy; Metastatic colorectal cancer; Bevacizumab